(Q39476163)

12 September 2017

Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study (English)

1 reference

multicenter clinical trial

12 September 2017

0 references

0 references

1 reference

Akpunonu BE

1

1 reference

12 September 2017

Mutgi AB

2

1 reference

12 September 2017

Federman DJ

3

1 reference

12 September 2017

Volinsky FG

4

1 reference

12 September 2017

Brickman K

5

1 reference

12 September 2017

Davis RL

6

1 reference

12 September 2017

Gilbert C

7

1 reference

12 September 2017

Asgharnejad M

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

12 September 2017

6

1 reference

Annals of Emergency Medicine

inferred from page(s)

published in

1 reference

12 September 2017

25

1 reference

12 September 2017

464-469

1 reference

12 September 2017

4

1 reference

Non-traumatic headache in the emergency department

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

A retrospective assessment of emergency department patients with complaint of headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

The Management of Non-traumatic Headache in a University Hospital Emergency Room

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Current emergency treatment of severe migraine headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Combination analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

A study of midrin in the symptomatic relief of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Treatment review: non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Ketorolac in acute headache management.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Intravenous chlorpromazine--preliminary results in acute migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Parenteral chlorpromazine treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

A comparative trial of three agents in the treatment of acute migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

1 reference

7 January 2021

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Healthcare resource and lost labour costs of migraine headache in the US.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970259-8

7 January 2021

10.1016/S0196-0644(95)70259-8

Identifiers

DOI

1 reference

12 September 2017

1 reference